Specific antibodies for RPSA and siRNAs targeting RPSA are two therapeutic strategies employed in many tumorigenic in vitro cell lines and both effective in inhibiting the characteristics of multiple cancer hallmarks [8, 50]. Here, RPSA is linked to cancer.